Form 8-K - Current report:
SEC Accession No. 0001641172-25-002001
Filing Date
2025-04-01
Accepted
2025-04-01 08:30:13
Documents
19
Period of Report
2025-04-01
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 43934
2 ex99-1.htm EX-99.1 3548
3 ex99-2.htm EX-99.2 16890
4 ex99-1_001.jpg GRAPHIC 486781
5 ex99-1_002.jpg GRAPHIC 538673
6 ex99-1_003.jpg GRAPHIC 565480
7 ex99-1_004.jpg GRAPHIC 511197
  Complete submission text file 0001641172-25-002001.txt   3141391

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE maia-20250401.xsd EX-101.SCH 3024
9 XBRL LABEL FILE maia-20250401_lab.xml EX-101.LAB 34240
10 XBRL PRESENTATION FILE maia-20250401_pre.xml EX-101.PRE 22365
21 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3784
Mailing Address 444 WEST LAKE STREET, SUITE 1700 CHICAGO IL 60606
Business Address 444 WEST LAKE STREET, SUITE 1700 CHICAGO IL 60606 312-416-8592
MAIA Biotechnology, Inc. (Filer) CIK: 0001878313 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41455 | Film No.: 25796794
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)